Tirzepatide (Mounjaro) is a once-weekly GLP-1/GIP medication that may help eligible patients manage appetite, support weight loss, and improve long-term weight management under medical supervision
Commercial and Employer-Sponsored Insurance Plans Whether your patient works for a government entity or a private employer, they will need to check with their specific healthcare plan
Call your provider if side effects are severe, last more than a few weeks, or you notice signs of allergic reaction or pancreatitis
"Resistance training prevents muscle loss induced by caloric restriction in obese elderly individuals." European Journal of Applied Physiology , 118(11), 2317-2327
GHRH-analogue / GHS combinations produce a larger GH pulse than either compound alone in published studies this is why most research protocols use ipamorelin with sermorelin, CJC-1295, or modified GRF(1-29) rather than as a monotherapy